BSX Boston Scientific Corporation Common Stock
$49,42
Prix · Aoû 21, 2026
Données fondamentales au Aoû 3, 2026
Fourchette 52 semaines
$42–$110
11% of range
Note des analystes
BUY
38 analysts
Objectif de cours
$63
+27% upside
P/E (TTM)
49.1
ROE
12.6%
Marge nette
14.4%
À propos de Boston Scientific Corporation Common Stock Présentation de l'entreprise depuis Wikipedia
Boston Scientific Corporation est une entreprise américaine spécialisée dans le matériel médical créée en 1979, basée à Natick, commercialisant ses produits dans le monde entier.
Lire la suite
Boston Scientific Corporation est une entreprise américaine spécialisée dans le matériel médical créée en 1979, basée à Natick, commercialisant ses produits dans le monde entier.
Histoire
En avril 2006, Boston Scientific a acquis l'entreprise américaine Guidant pour 27 milliards de dollars.
En mars 2015, Boston Scientific acquiert l'activité d'urologie masculine d'Endo International pour 1,65 milliard de dollars.
En mars 2017, Boston Scientific annonce pour 435 millions de dollars l'acquisition de Symetis, une entreprise suisse spécialisée dans le matériel médical vasculaire.
En novembre 2018, Boston Scientific annonce l'acquisition de BTG pour 3,3 milliards de livres.
En mars 2021, Boston Scientific annonce l'acquisition de Lumenis pour 1,07 milliard de dollars. En octobre 2021, Boston Scientific annonce l'acquisition de Baylis Medical, spécialisée dans les traitements radio de problèmes cardiovasculaires, pour 1,75 milliard de dollars.
En janvier 2026, Boston Scientific annonce l'acquisition pour 14,5 milliards de dollars de Penumbra, entreprise spécialisée dans le matériel médicale vasculaire.
Actionnaires
Liste des principaux actionnaires de l'entreprise au 17 avril 2022 :
Condamnations
Boston ScientificCorporation est condamné à 188 M$ pour allégations trompeuses sur ses bandelettes sous-urétrales pour l'incontinence urinaire(signalé par Prescrire (revue) en mars 22).
== Références ==
Source : Wikipedia, CC BY-SA 4.0 · Voir sur Wikipedia ↗
BSX Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$49.42
Capitalisation Boursière
—
P/E (TTM)
49.1
BPA (TTM)
$1.94
Revenus (TTM)
$20.07B
Rendement div.
—
ROE
12.6%
Dette/Capitaux propres
—
Fourchette 52 semaines
$42 – $110
BSX Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$20.07B
2016-12-31
→
2025-12-31
BPA
$1.94
2016-12-31
→
2025-12-31
Flux de trésorerie libre
$3.66B
2017-12-31
→
2025-12-31
Marges
14.4%
2017-12-31
→
2025-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
BSX
Médiane des pairs
P/E (TTM)
49.1
26.3
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
BSX
Médiane des pairs
Gross Margin (Marge Brute)
69.0%
63.1%
Operating Margin (Marge d'exploitation)
18.0%
—
Net Profit Margin (Marge nette)
14.4%
15.6%
ROA
7.0%
7.6%
ROE
12.6%
15.0%
ROIC
12.7%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
BSX
Médiane des pairs
Current Ratio (Ratio de liquidité)
1.6
1.7
Quick Ratio (Ratio de liquidité réduite)
0.4
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
BSX
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
19.9%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
16.5%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
15.2%
—
EPS YoY (BPA Année/Année)
55.2%
—
Net Income YoY (Bénéfice net YoY)
56.7%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
BSX
Médiane des pairs
BSX Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
38 analystes
- Achat fort 11 28,9%
- Achat 19 50,0%
- Conserver 8 21,1%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
29 analystes · 2026-08-19
Médiane
$60.00
Maintenant
$49.42
Bas
$44.00
Haut
$94.00
Objectif médian
$60.00
+21,4%
Objectif moyen
$62.69
+26,9%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.03%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $0.86 | $0.84 | 0.02% |
| 31 mars 2026 | $0.80 | $0.79 | 0.01% |
| 31 décembre 2025 | $0.80 | $0.79 | 0.01% |
| 30 septembre 2025 | $0.75 | $0.72 | 0.03% |
| 30 juin 2025 | $0.75 | $0.73 | 0.02% |
| 31 mars 2025 | $0.75 | $0.68 | 0.07% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.07B | $16.75B | $14.24B | $12.68B | $11.89B | $9.91B | $10.73B | $9.82B | $9.05B | $8.39B | $7.48B | $7.46B | |
| Cost of Revenue | $6.22B | $5.26B | $4.34B | $3.96B | $3.71B | $3.46B | $3.12B | $2.81B | $2.59B | $2.42B | $2.17B | $2.21B | |
| Gross Profit | $13.85B | $11.49B | $9.90B | $8.73B | $8.18B | $6.45B | $7.62B | $7.01B | $6.46B | $5.96B | $5.30B | $5.17B | |
| SG&A Expense | $6.89B | $5.98B | $5.19B | $4.52B | $4.36B | $3.79B | $3.94B | $3.57B | $3.29B | $3.10B | $2.87B | $2.90B | |
| Operating Expenses | $10.24B | $8.89B | $7.55B | $7.08B | $6.98B | $6.53B | $6.10B | $5.50B | $5.17B | $5.51B | $5.59B | $5.47B | |
| Operating Income | $3.61B | $2.60B | $2.34B | $1.65B | $1.20B | $-80M | $1.52B | $1.51B | $1.28B | $447M | $-283M | $-301M | |
| Interest Expense | $349M | $305M | $265M | $470M | $341M | $361M | $473M | $241M | $229M | $233M | $284M | $216M | |
| Other Non-op | $-228M | $-321M | $-358M | $-508M | $218M | $362M | $-358M | $156M | $-124M | $-37M | $-83M | $8M | |
| Pretax Income | $3.38B | $2.28B | $1.99B | $1.14B | $1.08B | $-79M | $687M | $1.42B | $933M | $177M | $-650M | $-509M | |
| Income Tax | $493M | $436M | $393M | $443M | $36M | $2M | $-4.01B | $-249M | $828M | $-170M | $-411M | $-390M | |
| Net Income | $2.89B | $1.85B | $1.59B | $698M | $1.04B | $-82M | $4.70B | $1.67B | $104M | $347M | $-239M | $-119M | |
| EPS (Basic) | $1.96 | $1.26 | $1.08 | $0.45 | $0.69 | $-0.08 | $3.38 | $1.21 | $0.08 | $0.26 | $-0.18 | $-0.09 | |
| EPS (Diluted) | $1.94 | $1.25 | $1.07 | $0.45 | $0.69 | $-0.08 | $3.33 | $1.19 | $0.08 | $0.25 | $-0.18 | $-0.09 | |
| Shares (Basic) | 1,480,400,000 | 1,471,500,000 | 1,453,000,000 | 1,430,500,000 | 1,422,300,000 | 1,416,700,000 | 1,391,500,000 | 1,381,000,000 | 1,370,100,000 | 1,357,600,000 | 1,341,200,000 | 1,324,300,000 | |
| Shares (Diluted) | 1,494,500,000 | 1,485,900,000 | 1,463,500,000 | 1,439,700,000 | 1,433,800,000 | 1,416,700,000 | 1,410,600,000 | 1,401,400,000 | 1,392,700,000 | 1,377,200,000 | 1,341,200,000 | 1,324,300,000 | |
| EBITDA | $4.98B | $3.87B | · | $2.79B | $2.29B | $1.04B | $2.53B | $2.40B | $2.13B | · | $442M | $424M |
Bilan 27
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.97B | $414M | $865M | $928M | $1.93B | $1.73B | $217M | $146M | $188M | $196M | $319M | $587M | |
| Inventory | $2.94B | $2.81B | $2.48B | $1.87B | $1.61B | $1.35B | $1.58B | $1.17B | $1.08B | $955M | $1.02B | $946M | |
| Prepaid Expense | $660M | $831M | $621M | $731M | $799M | $751M | $880M | $921M | $942M | $541M | $365M | $443M | |
| Other Current Assets | · | $831M | $621M | $731M | $799M | $751M | $880M | $921M | · | $240M | $254M | · | |
| Current Assets | $8.79B | $6.92B | $6.51B | $5.76B | $6.32B | $6.69B | $4.70B | $4.00B | $3.82B | $3.24B | $3.47B | $3.61B | |
| PP&E (Net) | $4.04B | $3.29B | $2.86B | $2.45B | $2.25B | $2.08B | $2.08B | $1.78B | $1.70B | $1.63B | $1.49B | $1.51B | |
| PP&E (Gross) | $7.64B | $6.83B | $6.34B | $5.73B | $5.53B | $5.31B | $5.17B | $4.74B | $4.62B | $4.37B | $4.06B | $3.85B | |
| Accum. Depreciation | $3.61B | $3.53B | $3.48B | $3.28B | $3.27B | $3.22B | $3.09B | $2.96B | $2.93B | $2.73B | $2.57B | $2.34B | |
| Goodwill | $18.28B | $17.09B | $14.39B | $12.92B | $11.99B | $9.95B | $10.18B | $7.91B | $7.00B | $6.68B | $6.47B | $5.90B | |
| Intangibles | $7.02B | $6.68B | $6.00B | $5.90B | $6.12B | $5.92B | $7.89B | $6.37B | $5.84B | $5.88B | $6.19B | $5.61B | |
| Other Non-current Assets | $1.19B | $1.75B | $1.53B | $1.50B | $1.41B | $1.92B | $1.53B | $845M | $688M | $666M | $505M | $407M | |
| Total Assets | $43.67B | $39.40B | $35.14B | $32.47B | $32.23B | $30.78B | $30.57B | $21.00B | $19.04B | $18.10B | $18.13B | $17.02B | |
| Accounts Payable | $1.14B | $960M | $942M | $862M | $794M | $513M | $542M | $349M | $530M | $447M | $209M | $262M | |
| Accrued Liabilities | $3.20B | $2.77B | $2.65B | $2.16B | $2.44B | $2.20B | $2.11B | $2.25B | $2.46B | $2.31B | $1.97B | $1.95B | |
| Current Liabilities | $5.44B | $6.40B | $4.93B | $3.80B | $4.27B | $3.68B | $4.87B | $5.26B | $5.65B | $3.59B | $2.43B | $2.85B | |
| Capital Leases | $446M | $401M | $390M | $347M | $389M | $401M | $276M | $0 | · | · | · | · | |
| Deferred Tax | $220M | $155M | $134M | $144M | $310M | $330M | $595M | $328M | $191M | $18M | $735M | $1.21B | |
| Other Non-current Liabilities | $2.40B | $1.87B | $1.97B | $2.04B | $2.22B | $2.31B | $2.63B | $1.88B | $2.37B | $2.34B | $2.97B | $2.67B | |
| Long-term Debt | · | · | · | · | · | · | · | · | $3.81B | $5.42B | $5.65B | $4.20B | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | $0 | $400M | |
| Common Stock | $17M | $17M | $17M | $17M | $17M | $17M | $16M | $16M | $16M | $16M | $16M | $16M | |
| Retained Earnings | $5.57B | $2.67B | $819M | $-750M | $-1.39B | $-2.38B | $-2.25B | $-6.95B | $-8.39B | $-8.58B | $-8.93B | $-8.69B | |
| Treasury Stock | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $1.72B | $1.72B | $1.72B | $1.72B | $1.72B | $1.72B | |
| AOCI | $-610M | $275M | $49M | $269M | $263M | $207M | $270M | $33M | $-59M | $1M | $88M | $144M | |
| Stockholders' Equity | $24.23B | $21.77B | $19.28B | $17.57B | $16.62B | $15.33B | $13.88B | $8.73B | $7.01B | $6.73B | $6.32B | $6.46B | |
| Liabilities + Equity | $43.67B | $39.40B | $35.14B | $32.47B | $32.23B | $30.78B | $30.57B | $21.00B | $19.04B | $18.10B | $18.13B | $17.02B | |
| Shares Outstanding | · | · | · | · | · | · | 1,394,922,641 | 1,384,581,760 | 1,373,496,628 | 1,362,104,547 | 1,346,647,516 | 1,327,451,966 |
Flux de trésorerie 19
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.37B | $1.27B | $1.20B | $1.14B | $1.09B | $1.12B | $1.01B | $894M | $844M | $815M | $769M | $725M | |
| Stock-based Comp | $299M | $266M | $233M | $220M | $194M | $170M | $157M | $140M | $127M | $116M | $107M | $103M | |
| Deferred Tax | $-12M | $-90M | $73M | $-7M | $-142M | $-85M | $-4.29B | $-162M | $244M | $-343M | $-605M | $-494M | |
| Amort. of Intangibles | $897M | $856M | $828M | $803M | $741M | $789M | $699M | $599M | $565M | $545M | $495M | $438M | |
| Restructuring | $101M | $16M | $69M | $24M | $40M | $52M | $38M | $36M | $37M | $28M | $26M | $69M | |
| Other Non-cash | $-13M | $144M | · | $-521M | $-316M | $382M | $256M | $-2.23B | $107M | · | $568M | $1.05B | |
| Operating Cash Flow | $4.53B | $3.44B | $2.50B | $1.53B | $1.87B | $1.51B | $1.84B | $310M | $1.43B | $1.18B | $691M | $1.27B | |
| CapEx | $876M | $790M | $711M | $588M | $554M | $376M | $461M | $316M | $319M | $376M | $247M | $259M | |
| Investing Cash Flow | $-2.64B | $-5.69B | $-2.57B | $-2.01B | $-1.60B | $-411M | $-5.04B | $-1.92B | $-1.01B | $-887M | $-2.19B | $-745M | |
| Net Debt Issued | · | · | · | · | · | · | $-3.56B | $-602M | $-1.00B | · | $-1.15B | $0 | |
| Stock Issued | · | · | · | $0 | $0 | $975M | $0 | $0 | $85M | $111M | $114M | $60M | |
| Stock Repurchased | · | · | · | $0 | $0 | $535M | $0 | $0 | · | $0 | $0 | $125M | |
| Net Stock Activity | · | · | · | $0 | $0 | $440M | $123M | $101M | $85M | · | $114M | $-65M | |
| Dividends Paid | · | $0 | $28M | $55M | $55M | $28M | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $-395M | $1.81B | $5M | $-548M | $-95M | $293M | $2.97B | $1.43B | $110M | $-206M | $1.28B | $-150M | |
| Net Change in Cash | $1.54B | $-450M | $-70M | $-1.04B | $173M | $1.39B | $-222M | $-188M | · | $-123M | $-268M | $370M | |
| Taxes Paid | $561M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $3.66B | $2.65B | · | $938M | $1.32B | $1.13B | $1.38B | $-6M | $1.11B | · | $353M | $1.01B | |
| Levered FCF | $3.36B | $2.40B | · | $650M | $986M | $762M | $-1.86B | $-289M | $1.08B | · | $249M | $960M |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.0% | 68.6% | · | 68.8% | 68.8% | 65.0% | 71.0% | 71.4% | 71.3% | · | 65.7% | 69.3% | |
| Operating Margin | 18.0% | 15.5% | · | 13.0% | 10.1% | -0.81% | 14.1% | 15.3% | 14.2% | · | -4.0% | -4.0% | |
| Net Margin | 14.4% | 11.0% | · | 5.5% | 8.8% | -0.83% | 43.8% | 17.0% | 1.1% | · | -3.0% | -1.6% | |
| Pretax Margin | 16.9% | 13.6% | · | 9.0% | 9.0% | -0.80% | 6.4% | 14.5% | 10.3% | · | -8.1% | -6.8% | |
| EBITDA Margin | 24.8% | 23.1% | · | 22.0% | 19.3% | 10.5% | 23.6% | 24.4% | 23.5% | · | 5.5% | 5.7% | |
| ROA | 7.0% | 5.0% | · | 2.2% | 3.3% | -0.27% | 18.2% | 8.3% | 0.56% | · | -1.4% | -0.71% | |
| ROE | 12.6% | 8.7% | · | 4.0% | 6.3% | -0.53% | 41.6% | 21.2% | 1.5% | · | -3.7% | -1.8% | |
| ROIC | 12.7% | 9.7% | · | 5.7% | 7.0% | -0.54% | 74.8% | 20.3% | 2.1% | · | -1.9% | -1.0% |
Liquidité et Solvabilité 4
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.1 | · | 1.5 | 1.5 | 1.8 | 1.0 | 0.8 | 0.7 | · | 1.4 | 1.3 | |
| Quick Ratio | 0.4 | 0.1 | · | 0.2 | 0.5 | 0.5 | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.2 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.1 | |
| Interest Coverage | 10.4 | 8.5 | · | 3.5 | 3.5 | -0.2 | 3.2 | 6.2 | 5.6 | · | -1.2 | -1.4 |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.3 | 0.4 | 0.5 | 0.5 | · | 0.5 | 0.4 | |
| Inventory Turnover | 2.2 | 2.0 | · | 2.3 | 2.5 | 2.4 | 2.3 | 2.5 | 2.6 | · | 2.2 | 2.4 |
Taux de croissance 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.9% | 17.6% | 12.3% | 6.7% | 19.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 16.5% | 12.1% | 12.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 15.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 55.2% | 16.8% | 137.8% | -34.8% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 62.7% | 21.9% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 56.7% | 16.0% | 128.1% | -33.0% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 60.6% | 21.0% | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20.07B | $16.75B | $14.24B | $12.68B | $11.89B | $9.91B | $10.73B | $9.82B | $9.05B | $8.39B | $7.48B | $7.46B | |
| Net Income TTM | $2.89B | $1.85B | $1.59B | $698M | $1.04B | $-82M | $4.70B | $1.67B | $104M | $347M | $-239M | $-119M | |
| Market Cap | · | · | · | · | · | · | $63.08B | $48.93B | $34.05B | · | $24.83B | $17.59B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | $24.51B | $17.40B | |
| P/E | 49.1 | 71.5 | 54.0 | 102.8 | 61.6 | -449.4 | 13.6 | 29.7 | 309.9 | 86.5 | -102.4 | -147.2 | |
| P/S | · | · | · | · | · | · | 5.9 | 5.0 | 3.8 | · | 3.3 | 2.4 | |
| P/B | · | · | · | · | · | · | 4.5 | 5.6 | 4.9 | · | 3.9 | 2.7 | |
| P / Cash Flow | · | · | · | · | · | · | 34.4 | 157.8 | 23.9 | · | 41.4 | 13.9 | |
| P / FCF | · | · | · | · | · | · | 45.9 | -8155.2 | 30.8 | · | 70.3 | 17.4 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | 55.5 | 41.0 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | 69.4 | 17.2 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | 3.3 | 2.3 | |
| Dividend Yield | · | · | · | · | · | · | 0.00% | 0.00% | · | · | · | · | |
| Earnings Yield | 2.0% | 1.4% | 1.8% | 0.97% | 1.6% | -0.22% | 7.4% | 3.4% | 0.32% | 1.2% | -0.98% | -0.68% | |
| Payout Ratio | · | 0.00% | · | 7.9% | 5.3% | -34.2% | · | · | · | · | · | · | |
| Annual Payout | · | $0 | $28M | $55M | $55M | $28M | $0 | $0 | · | · | · | · |
Compte de résultat 16
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.44B | $5.20B | $5.29B | $5.07B | $5.06B | $4.66B | $4.56B | $4.21B | $4.12B | $3.86B | $3.73B | $3.53B | $3.60B | $3.39B | $3.24B | $3.17B | |
| Cost of Revenue | $1.59B | $1.59B | $1.61B | $1.52B | $1.64B | $1.45B | $1.47B | $1.31B | $1.27B | $1.21B | $1.15B | $1.10B | $1.06B | $1.04B | $1.01B | $979M | |
| Gross Profit | $3.85B | $3.61B | $3.68B | $3.54B | $3.42B | $3.21B | $3.10B | $2.90B | $2.85B | $2.65B | $2.58B | $2.43B | $2.54B | $2.35B | $2.23B | $2.19B | |
| SG&A Expense | $1.80B | $1.78B | $1.83B | $1.74B | $1.72B | $1.60B | $1.61B | $1.56B | $1.45B | $1.36B | $1.38B | $1.24B | $1.35B | $1.22B | $1.16B | $1.13B | |
| Operating Expenses | $2.67B | $2.51B | $2.85B | $2.49B | $2.60B | $2.29B | $2.42B | $2.16B | $2.33B | $1.97B | $2.00B | $1.73B | $2.03B | $1.80B | $1.83B | $1.83B | |
| Operating Income | $1.18B | $1.10B | $825M | $1.05B | $819M | $921M | $675M | $733M | $520M | $675M | $584M | $693M | $514M | $552M | $402M | $358M | |
| Interest Expense | $96M | $90M | $90M | $87M | $90M | $82M | $80M | $79M | $77M | $69M | $64M | $66M | $70M | $65M | $64M | $63M | |
| Other Non-op | $-118M | $61M | $-124M | $-110M | $122M | $-116M | $-89M | $-65M | $-100M | $-67M | $-279M | $-18M | $-18M | $-43M | $-412M | $-51M | |
| Pretax Income | $1.06B | $1.16B | $700M | $939M | $941M | $805M | $585M | $669M | $420M | $608M | $505M | $610M | $426M | $444M | $395M | $245M | |
| Income Tax | $155M | $-176M | $31M | $183M | $146M | $133M | $23M | $200M | $98M | $115M | $1M | $105M | $156M | $131M | $256M | $57M | |
| Net Income | $905M | $1.34B | $670M | $755M | $795M | $672M | $563M | $468M | $322M | $493M | $504M | $504M | $270M | $314M | $140M | $188M | |
| EPS (Basic) | $0.62 | $0.90 | $0.45 | $0.51 | $0.54 | $0.46 | $0.38 | $0.32 | $0.22 | $0.34 | $0.35 | $0.34 | $0.18 | $0.21 | $0.09 | $0.12 | |
| EPS (Diluted) | $0.61 | $0.90 | $0.45 | $0.51 | $0.53 | $0.45 | $0.38 | $0.32 | $0.22 | $0.33 | $0.34 | $0.34 | $0.18 | $0.21 | $0.09 | $0.12 | |
| Shares (Basic) | 1,470,200,000 | 1,484,900,000 | -2,958,400,000 | 1,481,700,000 | 1,479,900,000 | 1,477,200,000 | -2,940,200,000 | 1,472,700,000 | 1,470,600,000 | 1,468,400,000 | -2,893,500,000 | 1,464,500,000 | 1,446,200,000 | 1,435,800,000 | -2,858,600,000 | 1,431,600,000 | |
| Shares (Diluted) | 1,474,800,000 | 1,495,000,000 | -2,987,600,000 | 1,495,500,000 | 1,493,500,000 | 1,493,100,000 | -2,967,400,000 | 1,487,400,000 | 1,484,200,000 | 1,481,700,000 | -2,913,700,000 | 1,475,000,000 | 1,456,200,000 | 1,446,000,000 | -2,876,500,000 | 1,440,000,000 | |
| EBITDA | $1.18B | $1.45B | · | $1.05B | $819M | $1.25B | · | $733M | $520M | $979M | · | $693M | $514M | $837M | · | $358M |
Bilan 24
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $539M | $1.45B | $1.97B | $1.27B | $534M | $725M | $414M | $2.50B | $2.91B | $2.33B | $865M | $952M | $426M | $570M | $928M | $338M | |
| Inventory | $3.23B | $3.12B | $2.94B | $2.92B | $2.86B | $2.87B | $2.81B | $2.75B | $2.61B | $2.56B | · | $2.40B | $2.25B | $2.05B | · | $1.79B | |
| Prepaid Expense | $760M | $729M | $660M | $701M | $613M | $756M | $831M | $674M | $756M | $671M | · | $741M | $773M | $711M | · | $884M | |
| Other Current Assets | · | · | · | $701M | $613M | $756M | · | $674M | $756M | $671M | · | $741M | $773M | $711M | · | $884M | |
| Current Assets | $7.97B | $8.68B | $8.79B | $8.04B | $7.12B | $7.33B | $6.92B | $8.76B | $8.99B | $8.19B | · | $6.50B | $5.89B | $5.70B | · | $5.14B | |
| PP&E (Net) | $4.13B | $4.06B | $4.04B | $3.79B | $3.46B | $3.39B | $3.29B | $3.07B | $2.95B | $2.90B | · | $2.63B | $2.53B | $2.48B | · | $2.27B | |
| PP&E (Gross) | $7.85B | $7.74B | $7.64B | $7.66B | $7.24B | $7.03B | $6.83B | $6.69B | $6.51B | $6.43B | · | $6.08B | $5.96B | $5.84B | · | $5.46B | |
| Accum. Depreciation | $3.73B | $3.67B | $3.61B | $3.86B | $3.78B | $3.64B | $3.53B | $3.62B | $3.56B | $3.53B | · | $3.45B | $3.43B | $3.36B | · | $3.19B | |
| Goodwill | $18.64B | $18.54B | $18.28B | $18.21B | $18.08B | $17.34B | $17.09B | $15.03B | $14.40B | $14.36B | $14.39B | $13.61B | $13.66B | $13.27B | $12.92B | $12.85B | |
| Intangibles | $6.92B | $7.06B | $7.02B | $7.16B | $7.26B | $6.57B | $6.68B | $5.75B | $5.42B | $5.84B | · | $5.85B | $6.06B | $6.06B | · | $6.06B | |
| Other Non-current Assets | $1.41B | $2.05B | $1.87B | $1.83B | $1.86B | $1.83B | $1.75B | $1.64B | $1.55B | $1.60B | · | $1.60B | $1.59B | $1.48B | · | $1.60B | |
| Total Assets | $45.22B | $44.35B | $43.67B | $42.71B | $41.56B | $40.14B | $39.40B | $38.08B | $37.11B | $36.67B | · | $34.04B | $33.60B | $32.89B | · | $31.95B | |
| Accounts Payable | $1.23B | $1.14B | $1.14B | $1.00B | $962M | $1.00B | $960M | $907M | $906M | $921M | · | $929M | $899M | $868M | · | $803M | |
| Accrued Liabilities | $2.76B | $2.51B | $3.20B | $2.98B | $2.80B | $2.35B | $2.77B | $2.46B | $2.32B | $2.08B | · | $2.25B | $2.16B | $1.92B | · | $1.97B | |
| Current Liabilities | $6.43B | $4.57B | $5.44B | $5.33B | $5.19B | $5.06B | $6.40B | $5.91B | $5.58B | $4.92B | · | $4.58B | $4.56B | $4.08B | · | $3.55B | |
| Capital Leases | · | · | $446M | $445M | $440M | $399M | $401M | $373M | $365M | $382M | · | $400M | $401M | $360M | · | $350M | |
| Deferred Tax | $221M | $219M | $220M | $242M | $226M | $158M | $155M | $138M | $132M | $132M | · | $91M | $135M | $210M | · | $278M | |
| Other Non-current Liabilities | $2.48B | $2.47B | $2.40B | $2.39B | $2.38B | $1.95B | $1.87B | $1.84B | $1.80B | $1.92B | · | $1.86B | $1.93B | $2.00B | · | $1.92B | |
| Common Stock | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | · | $17M | $17M | $17M | · | $17M | |
| Retained Earnings | $7.82B | $6.91B | $5.57B | $4.90B | $4.14B | $3.35B | $2.67B | $2.11B | $1.64B | $1.31B | · | $315M | $-189M | $-450M | · | $-876M | |
| Treasury Stock | $4.32B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | · | $2.25B | $2.25B | $2.25B | · | $2.25B | |
| AOCI | $-304M | $-398M | $-610M | $-689M | $-722M | $-28M | $275M | $-128M | $164M | $132M | · | $231M | $208M | $178M | · | $532M | |
| Stockholders' Equity | $24.93B | $25.86B | $24.23B | $23.39B | $22.42B | $22.21B | $21.77B | $20.71B | $20.37B | $19.93B | · | $18.89B | $18.23B | $17.85B | $17.57B | $17.64B | |
| Liabilities + Equity | $45.22B | $44.35B | $43.67B | $42.71B | $41.56B | $40.14B | $39.40B | $38.08B | $37.11B | $36.67B | · | $34.04B | $33.60B | $32.89B | · | $31.95B |
Flux de trésorerie 13
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $355M | $351M | $365M | $342M | $336M | $325M | $348M | $306M | $311M | $304M | $313M | $300M | $298M | $285M | $294M | $284M | |
| Stock-based Comp | $87M | $83M | $71M | $79M | $75M | $74M | $69M | $68M | $66M | $63M | $59M | $59M | $60M | $55M | $55M | $58M | |
| Amort. of Intangibles | $233M | $232M | $228M | $225M | $225M | $219M | $224M | $205M | $213M | $214M | $207M | $208M | $210M | $203M | $199M | $202M | |
| Restructuring | $8M | $3M | $16M | $-8M | $83M | $10M | $4M | $8M | $1M | $3M | $18M | $15M | $16M | $20M | $5M | $4M | |
| Other Non-cash | · | $-1.43B | · | · | · | $-530M | · | · | · | $-696M | · | · | · | $-464M | · | · | |
| Operating Cash Flow | $1.47B | $348M | $1.36B | $1.34B | $1.29B | $541M | $1.46B | $1.00B | $813M | $164M | $957M | $698M | $658M | $190M | $807M | $470M | |
| CapEx | $195M | $177M | $351M | $181M | $157M | $187M | $277M | $179M | $155M | $179M | $267M | $190M | $143M | $111M | $212M | $150M | |
| Investing Cash Flow | $-1.96B | $-591M | $-512M | $-502M | $-1.13B | $-500M | $-3.70B | $-1.43B | $-271M | $-285M | $-1.05B | $-197M | $-840M | $-484M | $-183M | $-225M | |
| Dividends Paid | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $0 | $14M | $14M | $13M | $14M | |
| Financing Cash Flow | $-410M | $-260M | $-184M | $-104M | $-340M | $233M | $214M | $7M | $24M | $1.57B | $15M | $16M | $43M | $-69M | $1M | $-199M | |
| Net Change in Cash | $-890M | $-504M | $671M | $735M | $-179M | $314M | $-2.04B | $-412M | $565M | $1.44B | $-77M | $513M | $-143M | $-363M | $629M | $39M | |
| Free Cash Flow | · | $171M | · | · | · | $354M | · | · | · | $-15M | · | · | · | $79M | · | · | |
| Levered FCF | · | $67M | · | · | · | $286M | · | · | · | $-71M | · | · | · | $33M | · | · |
Rentabilité 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.7% | 69.5% | · | 69.9% | 67.7% | 68.8% | · | 68.8% | 69.2% | 68.7% | · | 68.8% | 70.6% | 69.3% | · | 69.1% | |
| Operating Margin | 21.6% | 21.2% | · | 20.7% | 16.2% | 19.8% | · | 17.4% | 12.6% | 17.5% | · | 19.7% | 14.3% | 16.3% | · | 11.3% | |
| Net Margin | 16.6% | 25.7% | · | 14.9% | 15.7% | 14.4% | · | 11.1% | 7.8% | 12.8% | · | 14.3% | 7.5% | 9.3% | · | 5.9% | |
| Pretax Margin | 19.5% | 22.3% | · | 18.5% | 18.6% | 17.3% | · | 15.9% | 10.2% | 15.8% | · | 17.3% | 11.8% | 13.1% | · | 7.7% | |
| EBITDA Margin | 21.6% | 27.9% | · | 20.7% | 16.2% | 26.7% | · | 17.4% | 12.6% | 25.4% | · | 19.7% | 14.3% | 24.7% | · | 11.3% | |
| ROA | 2.1% | 3.2% | · | 1.9% | 2.0% | 1.8% | · | 1.3% | 0.91% | 1.4% | · | 1.5% | 0.82% | 0.96% | · | 0.59% | |
| ROE | 3.8% | 5.6% | · | 3.4% | 3.7% | 3.2% | · | 2.4% | 1.7% | 2.6% | · | 2.8% | 1.5% | 1.8% | · | 1.1% | |
| ROIC | 4.0% | 4.9% | · | 3.6% | 3.1% | 3.5% | · | 2.5% | 2.0% | 2.8% | · | 3.0% | 1.8% | 2.2% | · | 1.6% |
Liquidité et Solvabilité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.9 | · | 1.5 | 1.4 | 1.5 | · | 1.5 | 1.6 | 1.7 | · | 1.4 | 1.3 | 1.4 | · | 1.4 | |
| Quick Ratio | 0.1 | 0.3 | · | 0.2 | 0.1 | 0.1 | · | 0.4 | 0.5 | 0.5 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | |
| Interest Coverage | 12.3 | 12.2 | · | 12.0 | 9.1 | 11.2 | · | 9.3 | 6.8 | 9.8 | · | 10.5 | 7.3 | 8.5 | · | 5.7 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.6 |
Valorisation (TTM) 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20.77B | $19.99B | · | $19.00B | $18.05B | $16.85B | · | $15.71B | $15.10B | $14.37B | · | $13.69B | $13.40B | $12.83B | · | $12.37B | |
| Net Income TTM | $3.79B | $3.56B | · | $2.69B | $2.26B | $1.96B | · | $1.79B | $1.59B | $1.58B | · | $1.28B | $1.03B | $872M | · | $977M | |
| P/E | 16.7 | 26.3 | · | 53.9 | 70.7 | 76.4 | · | 69.3 | 72.0 | 64.6 | · | 62.1 | 79.5 | 87.8 | · | 60.5 | |
| Earnings Yield | 6.0% | 3.8% | · | 1.8% | 1.4% | 1.3% | · | 1.4% | 1.4% | 1.6% | · | 1.6% | 1.3% | 1.1% | · | 1.7% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | 0.00% | · | · | · | 4.5% | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $20.07B | $16.75B | $14.24B | $12.68B | $11.89B |
| Marge Brute % | 69.0% | 68.6% | — | 68.8% | 68.8% |
| Marge d'exploitation % | 18.0% | 15.5% | — | 13.0% | 10.1% |
| Résultat net | $2.89B | $1.85B | $1.59B | $698M | $1.04B |
| BPA dilué | $1.94 | $1.25 | $1.07 | $0.45 | $0.69 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 1.6 | 1.1 | — | 1.5 | 1.5 |
| Ratio de liquidité réduite | 0.4 | 0.1 | — | 0.2 | 0.5 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $3.66B | $2.65B | — | $938M | $1.32B |
Dernières actualités Actualités récentes mentionnant cette entreprise
- Boston Scientific’s Quarterly Earnings Preview: What You Need to Know
- BTIG Remains Bullish On Boston Scientific (BSX); Check Out What It Says About The Stock
- Boston Scientific Becomes Oversold (BSX)
- Why Boston Scientific Stock Was Sliding This Week
- Les actions de Boston Scientific montent après l'achat de 2 milliards de dollars et l'investissement dans MiRus (BSX)
- Voici ce que Piper Sandler pense de Boston Scientific Corp (BSX) maintenant
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 1 691 déclarants · $37.7B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 161 (-79 vs T. préc.) | 315 (+42 vs T. préc.) | 606 (-84 vs T. préc.) | 607 (-23 vs T. préc.) | +23.3M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $4 143 696 762 | 97 087 553 | 10,98% | Actions |
| STATE STREET CORP | $2 992 345 845 | 70 111 196 | 7,93% | Actions |
| PRIMECAP MANAGEMENT CO/CA/ | $2 156 232 608 | 50 520 914 | 5,72% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 271 556 448 | 29 792 794 | 3,37% | Actions |
| FMR LLC | $1 239 549 312 | 29 042 861 | 3,29% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $1 212 072 881 | 28 557 132 | 3,21% | Actions |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $994 184 207 | 23 293 913 | 2,64% | Actions |
| NORGES BANK | $903 536 838 | 21 170 029 | 2,40% | Actions |
| TWO SIGMA INVESTMENTS, LP | $826 243 102 | 19 359 023 | 2,19% | Actions |
| Capital World Investors | $717 600 310 | 16 812 257 | 1,90% | Actions |
| JANE STREET GROUP, LLC | $686 580 356 | 16 086 700 | 1,82% | Option d'achat |
| WELLINGTON MANAGEMENT GROUP LLP | $633 296 809 | 14 838 257 | 1,68% | Actions |
| Capital Research Global Investors | $605 255 716 | 14 180 571 | 1,60% | Actions |
| TWO SIGMA ADVISERS, LP | $600 558 161 | 6 298 460 | 1,59% | Actions |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $449 044 133 | 10 521 184 | 1,19% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $395 319 403 | 9 262 404 | 1,05% | Actions |
| Qube Research & Technologies Ltd | $381 720 146 | 8 943 771 | 1,01% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $356 182 867 | 8 345 428 | 0,94% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $325 241 617 | 7 620 469 | 0,86% | Actions |
| MORGAN STANLEY | $278 890 927 | 6 534 464 | 0,74% | Actions |
| D. E. Shaw & Co., Inc. | $254 250 351 | 5 957 131 | 0,67% | Actions |
| MAVERICK CAPITAL LTD | $253 414 762 | 5 937 553 | 0,67% | Actions |
| Ensign Peak Advisors, Inc | $251 016 744 | 5 881 367 | 0,67% | Actions |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $243 577 742 | 3 881 717 | 0,65% | Actions |
| UBS Group AG | $240 594 117 | 5 637 163 | 0,64% | Actions |
| JANE STREET GROUP, LLC | $238 521 448 | 5 588 600 | 0,63% | Option de vente |
| BlackRock, Inc. | $234 043 121 | 5 483 672 | 0,62% | Actions |
| LAZARD ASSET MANAGEMENT LLC | $227 443 076 | 5 329 032 | 0,60% | Actions |
| Clearbridge Investments, LLC | $218 981 454 | 5 130 774 | 0,58% | Actions |
| JARISLOWSKY, FRASER Ltd | $214 082 478 | 2 192 794 | 0,57% | Actions |
| BANK OF AMERICA CORP /DE/ | $211 692 928 | 4 960 003 | 0,56% | Actions |
| MILLENNIUM MANAGEMENT LLC | $210 735 360 | 5 437 567 | 0,56% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $208 893 933 | 4 894 422 | 0,55% | Actions |
| 1832 Asset Management L.P. | $194 487 468 | 4 556 876 | 0,52% | Actions |
| Holocene Advisors, LP | $180 429 700 | 4 227 500 | 0,48% | Option d'achat |
| Swiss National Bank | $178 906 024 | 4 191 800 | 0,47% | Actions |
| JANE STREET GROUP, LLC | $178 652 846 | 4 185 868 | 0,47% | Actions |
| Assenagon Asset Management S.A. | $178 127 498 | 4 173 559 | 0,47% | Actions |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $170 906 014 | 4 042 830 | 0,45% | Actions |
| National Pension Service | $168 995 643 | 3 959 598 | 0,45% | Actions |
| Legal & General Group Plc | $160 927 972 | 3 770 571 | 0,43% | Actions |
| Mitsubishi UFJ Asset Management Co., Ltd. | $154 393 705 | 3 617 472 | 0,41% | Actions |
| Ninety One UK Ltd | $149 464 716 | 3 501 985 | 0,40% | Actions |
| Sumitomo Mitsui Trust Group, Inc. | $146 301 705 | 3 427 875 | 0,39% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $144 322 114 | 2 299 954 | 0,38% | Actions |
| Employees Provident Fund Board | $143 349 316 | 3 358 700 | 0,38% | Actions |
| Vanguard Global Advisers, LLC | $142 456 877 | 3 337 790 | 0,38% | Actions |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $139 790 914 | 3 275 326 | 0,37% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $135 035 252 | 3 163 900 | 0,36% | Option d'achat |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $134 976 349 | 3 162 285 | 0,36% | Actions |
| Caisse de depot et placement du Quebec | $133 178 416 | 3 120 394 | 0,35% | Actions |
| Alecta Tjanstepension Omsesidigt | $133 002 390 | 3 117 000 | 0,35% | Actions |
| Mirova US LLC | $132 371 081 | 3 101 478 | 0,35% | Actions |
| BARCLAYS PLC | $131 524 822 | 3 081 650 | 0,35% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $122 627 792 | 2 873 191 | 0,33% | Actions |
| Public Sector Pension Investment Board | $119 712 961 | 2 804 896 | 0,32% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $115 346 242 | 2 702 583 | 0,31% | Actions |
| RHUMBLINE ADVISERS | $112 753 784 | 2 641 843 | 0,30% | Actions |
| Rathbones Group PLC | $108 402 974 | 2 539 901 | 0,29% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $102 944 373 | 2 412 005 | 0,27% | Actions |
| Temasek Holdings (Private) Ltd | $102 407 502 | 2 399 426 | 0,27% | Actions |
| Pictet Asset Management Holding SA | $102 158 094 | 2 393 080 | 0,27% | Actions |
| Unisphere Establishment | $101 911 304 | 2 387 800 | 0,27% | Actions |
| MILFORD FUNDS LTD | $92 593 577 | 2 169 484 | 0,25% | Actions |
| ALLIANCEBERNSTEIN L.P. | $91 340 092 | 1 455 619 | 0,24% | Actions |
| HSBC HOLDINGS PLC | $90 846 130 | 2 128 541 | 0,24% | Actions |
| GOLDMAN SACHS GROUP INC | $89 773 112 | 2 103 400 | 0,24% | Option d'achat |
| NOMURA HOLDINGS INC | $88 556 732 | 2 074 900 | 0,23% | Option d'achat |
| Cubist Systematic Strategies, LLC | $88 171 996 | 903 124 | 0,23% | Actions |
| NEUBERGER BERMAN GROUP LLC | $87 691 368 | 2 054 624 | 0,23% | Actions |
| California Public Employees Retirement System | $87 402 153 | 2 047 848 | 0,23% | Actions |
| Phoenix Financial Ltd. | $82 560 747 | 1 934 413 | 0,22% | Actions |
| Nuveen Asset Management, LLC | $76 820 023 | 860 054 | 0,20% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $73 919 754 | 1 731 953 | 0,20% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $73 776 648 | 1 728 600 | 0,20% | Option de vente |
| FIRST MANHATTAN CO. LLC. | $72 442 215 | 1 697 334 | 0,19% | Actions |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $71 276 539 | 1 670 022 | 0,19% | Actions |
| Banque Transatlantique SA | $71 260 298 | 914 874 | 0,19% | Actions |
| PRINCIPAL FINANCIAL GROUP INC | $70 441 674 | 1 650 461 | 0,19% | Actions |
| ROYAL BANK OF CANADA | $70 272 000 | 1 646 479 | 0,19% | Actions |
| Squarepoint Ops LLC | $69 351 970 | 1 624 929 | 0,18% | Actions |
| D. E. Shaw & Co., Inc. | $68 616 636 | 1 607 700 | 0,18% | Option de vente |
| GROUPAMA ASSET MANAGMENT | $68 098 768 | 1 571 750 | 0,18% | Actions |
| Lansforsakringar Fondforvaltning AB (publ) | $67 481 689 | 1 581 108 | 0,18% | Actions |
| Walleye Capital LLC | $67 356 381 | 1 578 172 | 0,18% | Actions |
| Squarepoint Ops LLC | $66 922 240 | 1 568 000 | 0,18% | Option d'achat |
| VANGUARD GROUP INC | $66 616 468 | 698 652 | 0,18% | Actions |
| GOLDMAN SACHS GROUP INC | $65 853 458 | 1 542 958 | 0,17% | Actions |
| CAPITAL FUND MANAGEMENT S.A. | $63 426 577 | 1 486 096 | 0,17% | Actions |
| ORBIMED ADVISORS LLC | $63 302 976 | 1 483 200 | 0,17% | Actions |
| TUDOR INVESTMENT CORP ET AL | $63 065 547 | 1 477 637 | 0,17% | Actions |
| CAXTON ASSOCIATES LP | $62 622 699 | 701 105 | 0,17% | Actions |
| ENVESTNET ASSET MANAGEMENT INC | $62 259 456 | 1 458 786 | 0,17% | Actions |
| AVIVA PLC | $61 094 158 | 1 431 447 | 0,16% | Actions |
| Navera Investment Management Ltd. | $60 925 063 | 1 427 592 | 0,16% | Actions |
| Connor, Clark & Lunn Investment Management Ltd. | $60 808 373 | 1 424 751 | 0,16% | Actions |
| JONES FINANCIAL COMPANIES LLLP | $56 948 391 | 1 287 551 | 0,15% | Actions |
| MENORA MIVTACHIM HOLDINGS LTD. | $56 913 780 | 1 333 500 | 0,15% | Actions |
| Schonfeld Strategic Advisors LLC | $56 634 266 | 1 326 951 | 0,15% | Actions |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $56 124 200 | 1 315 000 | 0,15% | Actions |
Initiés de la société 90 initiés · 30 dirigeants · 18 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| William Kucheman | Chief Executive Officer | 31 juillet 2012 P | 112 525 | 0 | 0 | $0 |
| James R Tobin | President & CEO | 24 février 2009 A | 550 000 | 0 | 0 | $0 |
| Jeffrey D Capello | EVP & Chief Financial Officer | 27 novembre 2013 S | 447 | 0 | 0 | $0 |
| Paul A Laviolette | COO | 1 juillet 2008 M | 63 072 | 0 | 0 | $0 |
| Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 31 juillet 2026 I | 64 198 | 0 | 7 | $-15 168 204 |
| Karen Prange | SVP&Pres, Uro & Pelvic Health | 8 mars 2016 S | 38 395 | 0 | 0 | $0 |
| Jean Fitterer Lance | SVP, Asst GC, Bus & Regions | 16 février 2015 M | 117 174 | 0 | 0 | $0 |
| John Michael Onuscheck | SVP & President, Europe | 1 janvier 2015 M | 116 025 | 0 | 0 | $0 |
| Kenneth Pucel | EVP, Glob Ops, Qual & Tech | 28 février 2014 M | 128 517 | 0 | 0 | $0 |
| Otha T. Spriggs III | SVP, Human Resources | 7 septembre 2012 M | 12 738 | 0 | 0 | $0 |
| Lawrence R Neumann | SVP, Special Projects | 10 mai 2012 M | 77 879 | 0 | 0 | $0 |
| Brian R Burns | EVP - Global Quality & Reg Aff | 28 février 2012 M | 79 418 | 0 | 0 | $0 |
| John B. Pedersen | Pres, Uro & Women's Health | 16 février 2012 M | 3 233 | 0 | 0 | $0 |
| Stephen F Moreci | SVP, Global Sales Operations | 1 juillet 2011 M | 37 362 | 0 | 0 | $0 |
| Sam R Leno | EVP & Chief Operations Officer | 6 juin 2011 M | 432 240 | 0 | 0 | $0 |
| Fred Colen | EVP & Chief Technology Officer | 10 mai 2010 M | 72 497 | 0 | 0 | $0 |
| James Gilbert | EVP, Strategy & Business Dev | 26 février 2010 A | 67 613 | 0 | 0 | $0 |
| David W Mcfaul | SVP, International | 12 février 2010 M | 41 426 | 0 | 0 | $0 |
| Donovan Paul | SVP, Corporate Communications | 12 février 2010 M | 33 103 | 0 | 0 | $0 |
| William F Mcconnell JR | SVP, Administration CRM | 24 juillet 2009 M | 55 204 | 0 | 0 | $0 |
| Donald S Baim | EVP, Chief Med. & Sci. Officer | 10 juillet 2009 M | 51 756 | 0 | 0 | $0 |
| Lucia Luce Quinn | Exec. Vice President-HR | 1 juillet 2009 M | 49 809 | 0 | 0 | $0 |
| Paul W Sandman | EVP and General Counsel | 29 février 2008 M | 66 846 | 0 | 0 | $0 |
| Jeffrey H Goodman | SVP, International | 1 juillet 2007 M | 10 460 | 0 | 0 | $0 |
| Lawrence C Best | EVP | 1 juillet 2007 F | 242 189 | 0 | 0 | $0 |
| Mark C Bartell | SVP Global Sales/Mkt CRM | 25 mai 2007 M | 1 812 | 0 | 0 | $0 |
| Mary E Russell | SVP and CMO | 3 janvier 2006 D | 4 706 | 0 | 0 | $0 |
| James H Taylor JR | Sr. VP, Operations | 9 février 2005 M | 9 360 | 0 | 0 | $0 |
| Dennis A Ocwieja | SVP, Regulatory | 3 janvier 2005 A | — | 0 | 0 | $0 |
| Robert G Maclean | SVP, HR | 3 janvier 2005 A | 36 502 | 0 | 0 | $0 |
| Edward J Ludwig | Administrateur | 31 juillet 2026 P | 30 359 | 2 | 0 | $430 314 |
| JOHNSON KRISTINA M | Administrateur | 3 mai 2016 A | 8 494 | 0 | 0 | $0 |
| Nicholas J Nicholas JR | Administrateur | 1 avril 2016 A | 0 | 0 | 0 | $0 |
| NICHOLAS PETER M | Administrateur | 1 avril 2016 A | 3 486 965 | 0 | 0 | $0 |
| Ernest Mario | Administrateur | 16 novembre 2015 S | 86 032 | 0 | 0 | $0 |
| Uwe E Reinhardt | Administrateur | 31 octobre 2014 A | 159 379 | 0 | 0 | $0 |
| Bruce L Byrnes | Administrateur | 31 octobre 2014 A | 112 097 | 0 | 0 | $0 |
| Katharine T Bartlett | Administrateur | 7 mai 2013 A | 52 464 | 0 | 0 | $0 |
| John Raymond Elliott | Administrateur | 27 février 2012 A | 603 676 | 0 | 0 | $0 |
| Ray J Groves | Administrateur | 31 mars 2011 A | 1 000 | 0 | 0 | $0 |
| Marye Anne Fox | Administrateur | 11 mai 2010 A | 21 111 | 0 | 0 | $0 |
| John E Pepper | Administrateur | 31 mars 2010 A | 58 807 | 0 | 0 | $0 |
| Ursula M Burns | Administrateur | 5 mai 2009 A | 32 001 | 0 | 0 | $0 |
| Warren B Rudman | Administrateur | 5 mai 2009 A | — | 0 | 0 | $0 |
| Nancy Ann Deparle | Administrateur | 6 mai 2008 A | 13 886 | 0 | 0 | $0 |
| Joel Lawrence Fleishman | Administrateur | 6 mai 2008 A | 125 691 | 0 | 0 | $0 |
| PROMERICA LP | Détenteur de 10% | 7 août 2007 J | 54 635 185 | 0 | 0 | $0 |
| Emily Woodworth | — | 11 août 2026 I | 2 930 | 0 | 0 | $0 |
| Jonathan Monson | — | 10 août 2026 I | 9 908 | 0 | 0 | $0 |
| David C Habiger | — | 5 août 2026 P | 17 160 | 5 | 0 | $407 941 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 7 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Boston Scientific Corporation, Boston Scientific Scimed, Inc. | 25 avril 2008 | — | Dépôt initial | Fusions et acquisitions / vente | SEC |
| GUIDANT CORPORATION ( | 3 février 2006 | — | Dépôt initial | Fusions et acquisitions / vente | SEC |
| Personne déclarante non divulguée | 14 février 2003 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 14 février 2003 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 27 juin 2002 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 23 mai 2002 | — | Dépôt initial | Fusions et acquisitions / vente | SEC |
| Personne déclarante non divulguée | 9 juillet 2001 | — | Dépôt initial | Fusions et acquisitions / vente | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 203 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| IHI · iShares Trust | 4,25% | 2 855 183 SH | 20 août 2026 | Quotidien |
| GDOC · Goldman Sachs ETF Trust | 3,78% | 15 740 NS | 31 mai 2026 | N-PORT |
| AGNG · Global X Funds | 2,44% | 41 335 NS | 31 mai 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 2,04% | 3 946 NS | 30 avril 2026 | N-PORT |
| POWA · Invesco Exchange-Traded Self-Indexe… | 1,72% | 59 686 SH | 20 août 2026 | Quotidien |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,68% | 15 586 NS | 30 avril 2026 | N-PORT |
| RUNN · Strategic Trust | 1,54% | 109 930 NS | 31 mai 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,52% | 244 511 SH | 20 août 2026 | Quotidien |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,47% | 649 521 SH | 20 août 2026 | Quotidien |
| FMED · Fidelity Covington Trust | 1,44% | 12 185 NS | 31 mai 2026 | N-PORT |
| HRTS · Tema ETF Trust | 1,42% | 15 285 NS | 31 mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1,38% | 683 394 NS | 30 avril 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1,23% | 29 571 NS | 30 avril 2026 | N-PORT |
| IYH · iShares Trust | 1,17% | 864 464 SH | 20 août 2026 | Quotidien |
| MEDI · Harbor ETF Trust | 1,10% | 5 252 NS | 30 avril 2026 | N-PORT |
| RXL · ProShares Trust | 1,04% | 15 464 NS | 31 mai 2026 | N-PORT |
| ESLG · Strategy Shares | 0,97% | 3 256 NS | 30 avril 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,93% | 4 467 628 SH | 19 août 2026 | Quotidien |
| ANEW · ProShares Trust | 0,92% | 1 476 NS | 31 mai 2026 | N-PORT |
| IXJ · iShares Trust | 0,92% | 779 800 SH | 20 août 2026 | Quotidien |
| GURU · Global X Funds | 0,83% | 8 375 NS | 30 avril 2026 | N-PORT |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 0,79% | 14 552 NS | 30 avril 2026 | N-PORT |
| PSET · Principal Exchange-Traded Funds | 0,74% | 5 002 NS | 30 juin 2026 | N-PORT |
| ESLV · Strategy Shares | 0,66% | 1 338 NS | 30 avril 2026 | N-PORT |
| DTEC · ALPS ETF Trust | 0,63% | 9 723 NS | 31 mai 2026 | N-PORT |
| ESUM · Strategy Shares | 0,62% | 16 531 NS | 30 avril 2026 | N-PORT |
| NBGX · Neuberger Berman ETF Trust | 0,60% | 1 844 NS | 31 mai 2026 | N-PORT |
| IIGD · Invesco Exchange-Traded Self-Indexe… | 0,56% | 160 000 | 20 août 2026 | Quotidien |
| FFLC · FIDELITY COVINGTON TRUST | 0,54% | 105 660 NS | 30 avril 2026 | N-PORT |
| ZECP · Zacks Trust | 0,52% | 36 519 NS | 31 mai 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,46% | 91 846 SH | 19 août 2026 | Quotidien |
| FFLG · FIDELITY COVINGTON TRUST | 0,46% | 46 964 NS | 30 avril 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0,43% | 57 055 NS | 30 avril 2026 | N-PORT |
| XOEF · iShares Trust | 0,42% | 1 861 SH | 20 août 2026 | Quotidien |
| CATH · Global X Funds | 0,40% | 83 468 NS | 30 avril 2026 | N-PORT |
| RCGE · EA Series Trust | 0,39% | 6 410 NS | 30 avril 2026 | N-PORT |
| JGLO · J.P. Morgan Exchange-Traded Fund Tr… | 0,39% | 477 916 NS | 30 avril 2026 | N-PORT |
| FWD · AB Active ETFs, Inc. | 0,39% | 230 737 NS | 31 mai 2026 | N-PORT |
| SNPG · DBX ETF Trust | 0,38% | 1 068 NS | 29 mai 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,37% | 56 542 NS | 30 avril 2026 | N-PORT |
| KRMA · Global X Funds | 0,36% | 8 982 NS | 31 mai 2026 | N-PORT |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0,36% | 250 378 NS | 30 avril 2026 | N-PORT |
| CRTC · DBX ETF Trust | 0,33% | 8 980 NS | 31 mai 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,30% | 8 685 000 | 20 août 2026 | Quotidien |
| OEI · Listed Funds Trust | 0,29% | 2 132 NS | 30 avril 2026 | N-PORT |
| CAPE · DoubleLine ETF Trust | 0,29% | 16 211 NS | 30 juin 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,29% | 713 544 NS | 30 avril 2026 | N-PORT |
| IWX · iShares Trust | 0,28% | 218 675 SH | 20 août 2026 | Quotidien |
| MGK · VANGUARD WORLD FUND | 0,28% | 2 161 888 SH | 19 août 2026 | Quotidien |
| HAPI · Harbor ETF Trust | 0,28% | 22 510 NS | 30 avril 2026 | N-PORT |